Open AccessAn implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis
Author(s) -
Michał Wasiak,
Mateusz Tajstra,
Dariusz A. Kosior,
Mariusz Gąsior
Publication year - 2023
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0041
Subject(s) - medicine , implantable cardioverter defibrillator , hazard ratio , cardiology , meta analysis , ischemic cardiomyopathy , sudden cardiac death , heart failure , randomized controlled trial , population , placebo , cardiomyopathy , cardiac resynchronization therapy , sudden death , confidence interval , ejection fraction , pathology , alternative medicine , environmental health
Recent data regarding the comparison of implantable cardioverter-defibrillator (ICD) therapy and optimal medical treatment in patients with non-ischemic cardiomyopathy has indicated no mortality benefit as a result of ICD therapy. Although the recommendations for ICD implantation did not change, it is worth noting that these findings significantly affected the daily practice of ICD implantation in Europe.